Aurobindo Pharma

In News

Trump tariff: Pharma stocks Aurobindo, DRL, Lupin, Sun Pharma in focus today; here's why - MSN

MSN - Jul 09, 2025

Aurobindo Pharma, Dr Reddy's, Lupin, other pharma stocks tumble up to 3% amid tariff jitters - Moneycontrol

Moneycontrol - Jul 08, 2025

Lupin, Biocon, Aurobindo Pharma And Laurus Labs Share Price Rise Despite U.S. Tariff Threat | Nifty Pharma Update - Samco

Samco - Jul 09, 2025

Aurobindo Pharma's US arm incorporates new subsidiary called Cresedemo Pharma - Times of India

Times of India - Jun 18, 2025

Buy Or Sell: Aurobindo Pharma, LIC Housing Finance On Ajit Mishras Radar — Check Target Price - NDTV Profit

NDTV Profit - Jul 04, 2025

Aurobindo gets Form 483 scolding from FDA at North Carolina inhaler plant - Fierce Pharma

Fierce Pharma - Apr 14, 2025

Aurobindo Pharma, BSE Limited among top losers on Nifty Midcap 150 - TradingView

TradingView - Jul 08, 2025

Petrucci: Construction underway on newest Aurobindo Pharma facility in East Windsor - RE-NJ

RE-NJ - Jan 14, 2025

Pharma Stocks Slide Up To 3% On US Tariff Concerns; Aurobindo, DRL, Lupin Among Top Losers - News18

News18 - Jul 08, 2025

Aurobindo Pharma shares in focus after European Commission nod for cancer drug Dazublys - The Economic Times

The Economic Times - Jul 03, 2025

Macquarie downgrades Aurobindo Pharma stock rating to Underperform By Investing.com - Investing.com UK

Investing.com UK - Jul 08, 2025

Aurobindo Pharma merges Pharmacin BV with Agile Pharma BV - Medical Dialogues

Medical Dialogues - Jul 03, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.